1Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol, 2003, 29: 1705-1713.
3Roulot D, Czemichow S, Le Clesiau H, et al. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol, 2008, 48: 606-613.
4Castera L, Foucher J, Bernard PH, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13, 369 examinations. Hepatology, 2010, 51: 828-835.
5Sirli R, Sporea I, Tudora A, et al. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointestin Liver Dis, 2009, 18: 57-60.
6Wong VW, Wong GL, Tsang SW, et al. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment Pharmacol Ther, 2009, 29: 387-396.
6SANDRIN L, FOURQUET B, HASQUENOPHJM, et al. Transient elastoqraphv, a new noninvasive method for assessment of hepatic fibrosis[J]. Ultrasound Med Bioi, 2003, 29 ( 12 ) : 1705 -1713.
7LlAWYF, LEUN N, KAOJH, etal. Asian-Pacificconsensus statement on the management of chronic hepatitis B: a 2012 update[J]. Hepatollnt, 2012, 6(3): 531 -561.
8European Association for The Study of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection[J].J Hepatol, 2012, 57(1): 167 -185.
9GUI HL, WANG H, YANG YH, et al. Significant histopathology in Chinese chronic hepatitis B patients with persistently high - normal alanine aminotransferase[J].J Viral Hepat, 2010,17[Suppl tJ , 44 -50.
10YUEN MF, YUAN HJ, WONG DK, et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications[J]. Gut, 2005, 54(11): 1610-1614.
